Physician Wealth Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Physician Wealth Advisors’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.92K	Hold	274	–	–	﹤0.01%	1103
2026 Q1	$3.81K	Hold	274	–	–	﹤0.01%	1101
2025 Q4	$3.31K	Hold	274	–	–	﹤0.01%	1097
2025 Q3	$3.72K	Hold	274	–	–	﹤0.01%	1006
2025 Q2	$1.76K	Hold	274	–	–	﹤0.01%	1095
2025 Q1	$970	Buy	+274	New	+$975	﹤0.01%	1085

Other funds holding AMLX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

IGAM

iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

CCIA

Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

FRM

Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Physician Wealth Advisors's AMLX Position: Q2 2026 in Review

Physician Wealth Advisors held its Amylyx Pharmaceuticals (AMLX) position steady in Q2 2026 at 274 shares worth $4.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1103.

Physician Wealth Advisors first reported a position in AMLX in Q1 2025 and has held it in 6 quarters since. 34 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

Physician Wealth Advisors held 274 shares of Amylyx Pharmaceuticals worth $4.92K as of Q2 2026.
Physician Wealth Advisors left its Amylyx Pharmaceuticals share count unchanged in Q2 2026.
Amylyx Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1103 holding.
Physician Wealth Advisors first reported a position in Amylyx Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
34 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.